Trials / Completed
CompletedNCT02189603
Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）
Evaluation of Safety and Immunogenicity of Recombinant (E. Coli) Hepatitis E Vaccine（Hecolin®） in Seniors Aged Over 65 Years
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 601 (actual)
- Sponsor
- Jun Zhang · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety and immunogenicity of the recombinant hepatitis E vaccine in people older than 65 years, and evaluate the efficacy of hepatitis E vaccine in this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Recombinant (E. Coli) Hepatitis E Vaccine |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-12-07
- Completion
- 2015-12-07
- First posted
- 2014-07-14
- Last updated
- 2018-08-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02189603. Inclusion in this directory is not an endorsement.